Pioneer of Human-Machine Integration and Deep Tech Disruption
Core Intelligence Domain: Technology & Innovation
Location: Stockholm, Sweden | Languages: English, Swedish
Representation: Represented globally by PSpeakers Global Intelligence
Hannes Sjoblad is an internationally recognised thought leader, deep tech investor, and strategic futurist specialising in the intersection of human augmentation, biohacking, and digital disruption. As the Chief Disruption Officer at Epicenter Stockholm and the Managing Director of Dsruptive Subdermals, he provides critical foresight to global organisations navigating the exponential technological shifts redefining the human-machine interface. His proprietary methodologies focus on exponential thinking and the “Connected Human” framework, equipping C-Suite leaders to anticipate disruptive trends and leverage radical technological convergence for sustainable strategic advantage.
With an extensive background in both business strategy and molecular biology, Sjoblad operates at the vanguard of the transhumanist and citizen science movements. He is universally acknowledged for his pioneering work in implantable technology, driving the paradigm shift from reactive medical treatment to proactive, continuous health monitoring. By spearheading initiatives that integrate micro-sensor technology into human physiology, he has fundamentally challenged conventional boundaries of privacy, data ownership, and biological integration, making him one of the most sought-after voices on the future of human capability.
His advisory portfolio extends across multinational corporations, governmental policy boards, and international technology summits. Through his leadership at Bionyfiken, the Swedish Association of Biohackers, he has democratised access to deep tech innovation, fostering a global community dedicated to ethical, progressive human enhancement.
Key Professional Milestones & Achievements
- Managing Director & Co-Founder of Dsruptive Subdermals: Spearheading the research, development, and commercialisation of frictionless, implantable health-logging technologies designed to revolutionise preventative healthcare.
- Chief Disruption Officer at Epicenter Stockholm: Architecting innovation frameworks and fostering an ecosystem of high-growth digital enterprises within Sweden’s premier innovation house.
- Co-Founder of Bionyfiken: Established the Swedish Association of Biohackers, successfully scaling a grassroots movement into an internationally recognised platform for citizen science and human augmentation advocacy.
- Global Media Recognition: Profiled for his groundbreaking work in human microchipping and bio-sensing by elite tier-one media, including the BBC, CNN, Wired, Le Figaro, and the Wall Street Journal.
- Strategic Advisor to Global Enterprises: Consults top-tier executives across the pharmaceutical, insurance, and telecommunications sectors on the commercial and ethical implications of near-field communication (NFC) implants and connected biology.
Core Speaking Themes & Strategic Frameworks
- The Biohacking Revolution: Upgrading the Human Enterprise: An exploration of how cognitive and physical augmentation is reshaping the future workforce, human performance, and corporate wellness strategies.
- Navigating Deep Tech Disruption: Strategies for C-Suite leaders to adopt an exponential mindset, ensuring organisational agility in an era dominated by rapid technological convergence.
- The Future of the Human-Machine Interface: Analysing the trajectory of connected biology, subdermal implants, and brain-computer interfaces, and their profound impact on data architecture and cybersecurity.
- Preventative Healthcare & The Smart Implant Paradigm: How implantable sensors and continuous vital monitoring will disrupt legacy healthcare models and drive the future of personalised medicine.
- Ethics, Privacy, and the Connected Human: A critical examination of data sovereignty, privacy rights, and the ethical governance required to safely integrate technology into the human body.
Key Takeaways
- Embrace Exponential Thinking: Leaders must shift from linear to exponential strategic planning to fully capitalise on rapid advancements in deep tech and biological sciences.
- Prepare for the “Connected Human” Era: Organisations must understand the strategic implications of a workforce and consumer base enhanced by embedded technologies and continuous health data streams.
- Prioritise Ethical Data Governance: As biological and digital data merge, establishing robust, transparent, and highly secure frameworks for data privacy is no longer optional, but a core commercial imperative.
- Leverage Citizen Science for Innovation: Fostering open, collaborative innovation environments can significantly accelerate research and development pipelines, providing a vital competitive edge in an unpredictable global market.
A PSpeakers Global Intelligence Briefing